ULURU Announces Approval to Market Altrazeal in Australia

Symbols: ULU
Posted in: News, FDA, Global
Share

ULURU Inc. (NYSE: ULU),announced today that an Australian Register of Therapeutic Goods Certificate has been issued by the Therapeutic Goods Administration approving the marketing of Altrazeal® in Australia.


 
 
< Previous
Exxon Mobil Corporation Announces 2011 Reserves Replacement
Next >
UPDATE: Tenaris Q4 Profit Surges 25%
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust